Kiselak Tomas insider trades
Kiselak Tomas has filed 17 Form 4s with the SEC that we hold, for Dianthus Therapeutics, Inc. /DE/ (DNTH) (Director), Viridian Therapeutics, Inc.\DE (VRDN) (Director), Oruka Therapeutics, Inc. (ORKA) (Director, 10% owner) and Apogee Therapeutics, Inc. (APGE) (Director), among 6 companies in all. Across all of them we count 5 purchases worth $4.1M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($3.0M) and 0 sales ($0). The largest single trade was a purchase of 150,000 shares of Zenas BioPharma, Inc. worth $3.0M, dated 2026-03-31. The first filing on our record is dated 2022-06-10 and the latest 2026-07-02.
Dianthus Therapeutics, Inc. /DE/ (DNTH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-09-12 | P, purchase reported on Form 4 | 14,887 | $161.5K | 2023-09-13 |
| 2023-09-13 | P, purchase reported on Form 4 | 9,367 | $110.2K | 2023-09-13 |
| 2023-09-19 | P, purchase reported on Form 4 | 30,000 | $396.0K | 2023-09-21 |
| 2023-09-26 | P, purchase reported on Form 4 | 30,000 | $394.5K | 2023-09-28 |
Viridian Therapeutics, Inc.\DE (VRDN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Oruka Therapeutics, Inc. (ORKA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Apogee Therapeutics, Inc. (APGE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Jade Biosciences, Inc. (JBIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zenas BioPharma, Inc. (ZBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-31 | P, purchase reported on Form 4 | 150,000 | $3.0M | 2026-04-01 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1830177) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms